SCHEMBL29307758

SCHEMBL29307758

CCN(C)Cc1ccccc1C1(c2ccccc2)c2ccccc2-c2ccccc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 3/20 0.38
▸ LMNA P02545 2/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ MEN1 O00255 2/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ OPRK1 P41145 1/20 0.38
▸ CYP2D6 P10635 2/20 0.36
▸ CYP1A2 P05177 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.33
▸ TACR1 P25103 1/20 0.33
▸ ESR1 P03372 1/20 0.33
▸ ESR2 Q92731 1/20 0.33
▸ CHRNB2 P17787 1/20 0.32
▸ CHRNA4 P43681 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.31
▸ KIF11 P52732 1/20 0.31
▸ CYP19A1 P11511 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29307756 0.82 KMT2A (0.45) KMT2ALMNASMN1; SMN2MEN1KDM4E
SCHEMBL19735233 0.81 LMNA (0.37) KMT2ALMNASMN1; SMN2MEN1KDM4E
SCHEMBL29307757 0.78 KMT2A (0.42) KMT2ALMNASMN1; SMN2MEN1KDM4E
SCHEMBL19735235 0.78 LMNA (0.37) KMT2ALMNASMN1; SMN2MEN1KDM4E
SCHEMBL25708805 0.74 MEN1 (0.44) KMT2ALMNASMN1; SMN2MEN1KDM4E
SCHEMBL17903074 0.71 KMT2A (0.46) KMT2ALMNASMN1; SMN2MEN1KDM4E
SCHEMBL17854959 0.71 ADORA2A (0.43) KMT2ALMNASMN1; SMN2MEN1KDM4E
SCHEMBL17903075 0.70 MEN1 (0.49) KMT2ALMNASMN1; SMN2MEN1KDM4E
SCHEMBL129053 0.70 MEN1 (0.67) KMT2ALMNASMN1; SMN2MEN1KDM4E
SCHEMBL29392072 0.70 MEN1 (0.67) KMT2ALMNASMN1; SMN2MEN1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12041847-B2 Compound for organic electric element, organic electric element using the same, and electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2024-07-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12041847-B2 Compound for organic electric element, organic electric element using the same, and electronic device thereof ORAI2, OR51E2, OR10J3 KMT2A 662/4885LMNA 2446/4885SMN1; SMN2 1604/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback